Xsensio Advances Continuous Biochemical Monitoring With Lab-on-Skin™
Wearable technology has changed how people track their health. Today, many devices measure movement, heart rate, sleep, and activity. However, these devices mainly track physical signals.
The next generation of wearables could offer a deeper view of health. Instead of tracking only physical changes, they could also monitor biochemical signals inside the body.
Xsensio, a Propel(x) portfolio company, is developing technology for this approach. Its Lab-on-Skin™ platform aims to support continuous biochemical monitoring through a wearable system.
A New Approach to Wearable Health Monitoring
Traditional wearable devices can provide useful information about physical activity and vital signs. However, they do not usually measure biochemical signals.
Xsensio is working to expand what wearable devices can monitor.
Its Lab-on-Skin™ platform uses several technologies to measure biomarkers at the skin. These technologies include nanotechnology, biochemistry, microfluidics, and miniaturized semiconductor technology.
Together, they support a wearable approach to biochemical sensing.
Measuring Biomarkers From the Body
The Lab-on-Skin™ platform focuses on interstitial fluid. This fluid sits between the body’s cells and contains different types of biological information.
Xsensio’s technology can target several types of biomarkers. These include:
- Metabolites
- Ions
- Proteins
- Hormones
As a result, the platform could provide information that traditional wearables cannot capture.
The goal is to monitor these signals continuously. This could help researchers study how biomarkers change over time.
Why Continuous Biochemical Monitoring Matters
Health changes do not always happen at a single point in time. Biomarker levels can change throughout the day or during different stages of a condition.
For this reason, continuous monitoring could provide a more complete picture.
Instead of relying only on occasional measurements, healthcare teams could potentially collect data over longer periods. This information could help researchers better understand changes in the body.
In addition, continuous data could complement information from traditional medical tests and wearable devices.
Xsensio and Texas Instruments
Xsensio recently announced a long-term collaboration with Texas Instruments.
The companies plan to advance the integration and miniaturization of Xsensio’s biosensing technology. This work could help support smaller and more integrated wearable systems.
Moreover, semiconductor technology plays an important role in building compact sensing devices. Therefore, this collaboration could support Xsensio’s efforts to develop practical wearable biosensing technology.
Exploring Healthcare Applications
Xsensio is exploring several potential applications for its Lab-on-Skin™ platform.
These include:
- Critical care
- Oncology
- Surgical recovery
- Preventive healthcare
Each area presents different monitoring needs. However, they share an interest in understanding changes in the body over time.
Continuous biochemical monitoring could provide another source of health information in these settings. The company continues to develop and evaluate the technology for these potential applications.
Combining Multiple Technologies
One of the key features of Xsensio’s approach is its combination of different technologies.
The Lab-on-Skin™ platform brings together sensing, microfluidics, biochemistry, and semiconductor technology. Each component plays a role in collecting and analyzing biological information.
This combination allows Xsensio to explore wearable devices that can monitor more than physical signals.
Furthermore, the platform can target different biomarkers based on the needs of a specific application. This flexibility could support a range of healthcare and research use cases.
Advancing the Future of Wearable Technology
Wearable technology continues to expand beyond fitness and activity tracking. At the same time, advances in biosensing are creating new ways to collect health data.
Xsensio is working at the intersection of these developments.
Its Lab-on-Skin™ platform is designed to bring biochemical monitoring into a wearable format. The company is also working with Texas Instruments to advance the integration and miniaturization of its technology.
As development continues, this approach could open new possibilities for continuous health monitoring.
The broader goal is simple: provide more information about what is happening inside the body.
We’re proud to see the Xsensio team continue advancing its Lab-on-Skin™ platform and exploring new possibilities for continuous biochemical monitoring.
Learn more about Xsensio on Propelx.com.
